498 results Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advised Mainfreight Stibbe advised ABN AMRO Representing ABN AMRO in a major dispute with inter alia former group companies Fortis N.V. and Fortis SA/NV (renamed: Ageas). Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises leading Belgian bank Stibbe assisted a leading Belgian bank with a number of highly complex and sensitive litigation cases about the sale of Collateralized Debt Obligations (CDOs) to corporate and private clients during the period 2005-2007. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Stibbe advises Belgocontrol Stibbe assisted Belgocontrol in legal proceedings pursued by Ryanair, BATA, and others to seek damages for the losses they incurred because of the spontaneous strikes by Brussels Airport’s air-traffic controllers in 2009. Stibbe represents the Flemish Region Stibbe assisted the Flemish Region in an EU litigation by defending its interests based on Article 258 of the Treaty on the Functioning of the European Union (TFEU, previously Article 226 TEC). Stibbe represents Heineken Stibbe represents Heineken as a major creditor in the bankruptcy of the catering company Plassania. Press release: ATB declared bankrupt, Daisy Nijkamp and Job van Hooff appointed bankruptcy trustees On 22 April 2022, Amsterdam Trade Bank N.V. ("ATB") filed for bankruptcy and was declared bankrupt by the Amsterdam District Court. The court appointed D.D. Nijkamp and J.E.P.A. van Hooff as bankruptcy trustees. Stibbe assists New Mountain Capital Stibbe assisted New Mountain Capital with Luxembourg legal aspects related to the signing of a purchase agreement pursuant to which Grant Thornton Luxembourg will join a new transatlantic professional services platform led by Grant Thornton Advisors LLC. Dario Baltussen Junior Associate Amsterdam Louis Vandercruysse Junior Associate Brussels Pagination Previous page Page 25 Page 26 Current page 27 Page 28 Next page
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advised ABN AMRO Representing ABN AMRO in a major dispute with inter alia former group companies Fortis N.V. and Fortis SA/NV (renamed: Ageas).
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises leading Belgian bank Stibbe assisted a leading Belgian bank with a number of highly complex and sensitive litigation cases about the sale of Collateralized Debt Obligations (CDOs) to corporate and private clients during the period 2005-2007.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Stibbe advises Belgocontrol Stibbe assisted Belgocontrol in legal proceedings pursued by Ryanair, BATA, and others to seek damages for the losses they incurred because of the spontaneous strikes by Brussels Airport’s air-traffic controllers in 2009.
Stibbe represents the Flemish Region Stibbe assisted the Flemish Region in an EU litigation by defending its interests based on Article 258 of the Treaty on the Functioning of the European Union (TFEU, previously Article 226 TEC).
Stibbe represents Heineken Stibbe represents Heineken as a major creditor in the bankruptcy of the catering company Plassania.
Press release: ATB declared bankrupt, Daisy Nijkamp and Job van Hooff appointed bankruptcy trustees On 22 April 2022, Amsterdam Trade Bank N.V. ("ATB") filed for bankruptcy and was declared bankrupt by the Amsterdam District Court. The court appointed D.D. Nijkamp and J.E.P.A. van Hooff as bankruptcy trustees.
Stibbe assists New Mountain Capital Stibbe assisted New Mountain Capital with Luxembourg legal aspects related to the signing of a purchase agreement pursuant to which Grant Thornton Luxembourg will join a new transatlantic professional services platform led by Grant Thornton Advisors LLC.